Managing Emergencies: The MSUD Crisis Plan
At a Glance
An MSUD crisis can worsen quickly when illness or fasting causes leucine to rise. Call the metabolic team at the first warning sign, follow the child's written sick-day protocol, and seek emergency care for persistent vomiting, inability to drink, or neurological changes.
An acute metabolic decompensation is a life-threatening emergency for a child with Maple Syrup Urine Disease (MSUD). It happens when the body enters a state of catabolism (breaking down its own muscle and tissue), which releases a flood of leucine into the bloodstream [1][2].
Because high leucine levels cause the brain to swell (cerebral edema), acting quickly at the first sign of trouble can prevent permanent neurological damage or life-threatening complications [3][4].
IMPORTANT WARNING: You must follow the individualized, written emergency protocol provided by your metabolic specialist. Call your metabolic team immediately at the first sign of illness. Do not improvise your child’s care.
Recognizing the Early Warning Signs
A crisis often starts subtly. You may notice “soft” signs before your child appears severely ill. Do not wait for neurological symptoms to appear before calling your metabolic team [5].
- Early Red Flags: Poor feeding, refusal of formula, unusual tiredness (malaise), and decreased activity [5][6]. Any change in alertness is a reason to call.
- Physical Symptoms: Repeated vomiting, diarrhea, or signs of dehydration (fewer wet diapers, dry mouth) [5].
- The “Maple” Scent: A sweet odor in the urine or earwax may become much stronger as leucine levels rise, but it may also be absent. Do not wait for this odor to seek care [7].
- Laboratory Clues: If you are testing at home, the presence of ketones in the urine (ketonuria) can occur, but negative ketones do not mean your child is safe [5][6]. Never wait for a ketone result or rely on it to decide whether to seek care.
Triggers of a Crisis
A crisis is usually triggered by a “stressor” that forces the body to use its own protein for energy. Common triggers include:
- Infections and high fevers [2].
- Gastroenteritis (stomach flu) causing vomiting or diarrhea [8].
- Prolonged fasting or skipped meals.
- Surgery or major physical injury [9].
The Sick-Day Plan: Action at Home
Every family must have a written emergency protocol or “sick-day letter” from their metabolic specialist. This letter is your most important tool in an emergency [10]. The steps below are only examples of what your plan might include; always follow your exact prescription.
- Modify Natural Protein: Your team may instruct you to temporarily modify natural protein (meat, dairy, etc.), but never improvise changes to natural protein or medical formula on your own [11][12].
- Increase Carbohydrates: To stop the body from breaking down its own muscle, you may need to provide a “fuel” source of high-carbohydrate drinks every few hours, even through the night, as specifically prescribed by your team [13][10].
- BCAA-Free Formula: Continue providing the specialized formula as directed by your team to keep other amino acids balanced [11].
- When to Go to the Hospital: If your child cannot keep down their sick-day fluids, or if they become excessively sleepy or irritable, you must go to the emergency room immediately [14].
Hospital Management: Intensive Care
Once at the hospital, the goal is to aggressively stop catabolism and flush out the excess leucine.
- IV Fluids and Glucose: The medical team will start high-rate IV fluids containing dextrose (sugar) and often lipids (fats) to provide a massive amount of calories and stop the “muscle breakdown” signal [11][13].
- BCAA-Free IV Solutions: If your child cannot drink their formula, doctors may use a specialized BCAA-free IV solution to provide essential building blocks without adding more leucine [14][15].
- Insulin Therapy: In some cases, doctors may use an insulin drip along with the IV glucose to help drive amino acids out of the blood and into the cells [16][9].
Emergency Intervention: Dialysis and CRRT
If leucine levels are rising dangerously high or if your child shows signs of brain swelling, the team may use extracorporeal treatment [3][17].
- Hemodialysis or CRRT (Continuous Renal Replacement Therapy): These are forms of dialysis that act like an artificial kidney to rapidly filter leucine directly out of the blood [3][18].
- Why it’s used: These therapies are a fast way to lower leucine. There is no single universal cutoff number; the specialist team makes this decision based on the level, rate of rise, and neurologic findings. Treatment must not be delayed while waiting for a particular number [17][19].
Emergency Neurological Signs (Call 911 or Go to ER):
Common questions in this guide
What are the first signs of an MSUD crisis?
What should I do if my child with MSUD is sick or cannot eat?
Can a negative urine ketone test rule out an MSUD crisis?
When should I call 911 or take my child with MSUD to the hospital?
What treatments can a hospital use during an MSUD crisis?
What should be included in my child's MSUD emergency plan?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is our specific 'hospital trigger'—at what point of vomiting or refusal to eat should we head to the ER?
- 2.Do we have an up-to-date 'sick-day letter' and does it include instructions for IV BCAA-free solutions?
- 3.Which local hospital has the capability to perform CRRT or hemodialysis if my child has a severe crisis?
- 4.In an emergency, how frequently will you be monitoring my child's leucine and electrolyte levels?
- 5.If my child needs surgery, what is the specific plan for their IV fluids and glucose to prevent a crisis?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Clues and challenges in the diagnosis of intermittent maple syrup urine disease.
Pode-Shakked N, Korman SH, Pode-Shakked B, et al.
European journal of medical genetics 2020; (63(6)):103901 doi:10.1016/j.ejmg.2020.103901.
PMID: 32151765 - 2
[Maple syrup urine disease decompensation - rare but life-threatening].
Vogt K, Baumgartner M, Timper K
Praxis 2025; (114(6)):257-260 doi:10.23785/PRAXIS.2025.06.010.
PMID: 40525928 - 3
Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.
Aygün F, Kıykım E, Aktuğlu-Zeybek Ç, et al.
The Turkish journal of pediatrics 2019; (61(1)):107-110.
PMID: 31559730 - 4
EEG Pattern in Neonatal Maple Syrup Urine Disease: Description and Clinical Significance.
Poothrikovil RP, Al Thihli K, Al Futaisi A
The Neurodiagnostic journal 2021; (61(3)):123-131 doi:10.1080/21646821.2021.1935628.
PMID: 34449278 - 5
Predictors of acute metabolic decompensation in children with maple syrup urine disease at the emergency department.
Yıldız Y, Akcan Yıldız L, Dursun A, et al.
European journal of pediatrics 2020; (179(7)):1107-1114 doi:10.1007/s00431-020-03602-x.
PMID: 32048023 - 6
Early laboratory indicators of acute metabolic decompensation during emergency presentations in pediatric maple syrup urine disease.
Oral-Cebeci S, Aktuğlu-Zeybek Ç, Aslan B, et al.
European journal of pediatrics 2026; (185(6)).
PMID: 42151652 - 7
Maple syrup urine disease: mechanisms and management.
Blackburn PR, Gass JM, Vairo FPE, et al.
The application of clinical genetics 2017; (10()):57-66 doi:10.2147/TACG.S125962.
PMID: 28919799 - 8
Acute Metabolic Crises in Maple Syrup Urine Disease After Liver Transplantation from a Related Heterozygous Living Donor.
Al-Shamsi A, Baker A, Dhawan A, Hertecant J
JIMD reports 2016; (30()):59-62 doi:10.1007/8904_2016_532.
PMID: 27117295 - 9
Case Report: Graves' disease in a toddler with maple syrup urine disease: therapeutic challenges and surgical resolution.
Ghandora H, Alzahrani MK, Alsharif RL, et al.
Frontiers in pediatrics 2026; (14()):1803842 doi:10.3389/fped.2026.1803842.
PMID: 42199498 - 10
Treatment of COVID-19 in a Patient With Maple Syrup Urine Disease.
Morton KF, Goetz RL, Linscott KB, Van Wagoner NJ
Cureus 2022; (14(4)):e24368 doi:10.7759/cureus.24368.
PMID: 35619835 - 11
Alternative sources of valine and isoleucine for prompt reduction of plasma leucine in maple syrup urine disease patients: A case series.
Ziadlou M, MacDonald A
JIMD reports 2022; (63(6)):555-562 doi:10.1002/jmd2.12327.
PMID: 36341173 - 12
Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
Deon M, Guerreiro G, Girardi J, et al.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2023; (83(6)):489-504 doi:10.1002/jdn.10283.
PMID: 37340513 - 13
Hyperleucinosis during infections in maple syrup urine disease post liver transplantation.
Guilder L, Prada CE, Saenz S, et al.
Molecular genetics and metabolism reports 2021; (27()):100763 doi:10.1016/j.ymgmr.2021.100763.
PMID: 33996492 - 14
Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study.
Alili JM, Berleur MP, Husson MC, et al.
Orphanet journal of rare diseases 2022; (17(1)):202 doi:10.1186/s13023-022-02353-2.
PMID: 35578286 - 15
Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease.
Sánchez-Pintos P, Meavilla S, López-Ramos MG, et al.
Frontiers in pediatrics 2022; (10()):969741 doi:10.3389/fped.2022.969741.
PMID: 36046474 - 16
Changes in branched-chain amino acids in an infant with maple syrup urine disease during perioperative pediatric liver transplant: A case report.
Saeyup P, Tubjaroen C, Kamolvisit W, et al.
Paediatric anaesthesia 2024; (34(4)):366-370 doi:10.1111/pan.14842.
PMID: 38314877 - 17
Continuous Venovenous Hemodiafiltration in the Treatment of Maple Syrup Urine Disease.
Demirkol D, Şık G, Topal N, et al.
Blood purification 2016; (42(1)):27-32 doi:10.1159/000443783.
PMID: 26998605 - 18
Treatment strategies, radiological recovery, and neurodevelopmental outcomes in paediatric Maple Syrup Urine Disease: a 20-year single-centre experience from Türkiye.
Uylaş K, Yazıcı H, Altınok YA, et al.
Metabolic brain disease 2026; (41(1)).
PMID: 42329506 - 19
Differential response to renal replacement therapy in neonatal-onset inborn errors of metabolism.
Porta F, Peruzzi L, Bonaudo R, et al.
Nephrology (Carlton, Vic.) 2018; (23(10)):957-961 doi:10.1111/nep.13409.
PMID: 29888426
This page is for informational purposes and emergency preparation only; it does not constitute medical advice or replace your child's individualized protocol from a metabolic specialist. Call your metabolic team immediately and follow its instructions during illness.
Get notified when new evidence is published on Maple syrup urine disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.